advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (5)
Showing records 1 to 5
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor47865 Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
Mizoguchi T; Ozaki M; Wakiyama H; Ogino N
Clinical Ophthalmology 2011; 5: 1515-1520
47603 Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients
Popa SA; Bucatariu PM; Azoicahi D; Costin D; Manole A; Matei M; Merchez M
Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2011; 115: 455-459
47670 Comparative study of the pressure lowering efficacy and variations in the ocular pulse amplitude between fixed combinations of dorzolamide/timolol and brinzolamide/timolol
Sanchez-Pulgarin M; Martinez-de-la-Casa JM; Garcia- Feijoo J; Saenz-Frances F; Santos-Bueso E; Herrero-Vanrell R; Garcia Sanchez J
Archivos de la Sociedad Española de Oftalmologia 2011; 86: 149-153
47925 From dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month, multicenter, open-label tolerability switch study
Rossi GCM; Pasinetti GM; Sandolo F; Bordin M; Bianchi PE
Expert Opinion in Pharmacotherapy 2011; 12: 2425-2431
47869 Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
Syed MF; Loucks EKR
Clinical Ophthalmology 2011; 5: 1291-1296
